Mega Lifesciences

What Mega Lifesciences does

Mega Lifesciences Public Company Limited (ticker: MEGA on the Stock Exchange of Thailand; founded 1982; HQ Bang Na, Thailand; 5,001-10,000 employees) is a public pharmaceutical and nutraceutical company that manufactures, markets and distributes more than 500 products across 30+ countries under the master brand Mega We care. Its commercial portfolio is split across three pillars: (1) Wellness & Nutrition — OTC vitamins, minerals, probiotics, herbal medicines, and condition-specific supplements (e.g., Calcivita Forte, Flexsa 1500, NORMAGUT, Livolin Forte, FERROVIT) sold to consumers through retail pharmacy and direct channels; (2) Prescription Medicines — branded Rx products across 15 therapy areas including anti-infective, cardiovascular, dermatology, diabetes, gastrointestinal, gynaecology, oncology and respiratory, sold through healthcare practitioners; and (3) Market Access & Digital Wellness — Maxx Care distribution services in Myanmar, Vietnam and Cambodia, plus consumer digital platforms (Good Health By Yourself, Women We care, Wellness We care Center, joinwecare health apps, e-learning, health calculators and risk assessment tools).

The company makes money primarily through one-time product sales (Rx and OTC) with pricing set by country-specific regulatory regimes for prescription medicines, supplemented by transaction-fee revenue from Maxx Care distribution partnerships in three Southeast Asian markets and professional-services revenue from Wellness We care Center programs. Q4 2025 revenue was THB 3.66 billion (reported +0.2% YoY, +9.3% normalized; branded business +4.2%, distribution +19.1% normalized), Q1 2026 results exceeded expectations, and management has committed approximately THB 2.7 billion in CapEx over 2026-2028 to build new manufacturing capacity in Vietnam, Indonesia and Myanmar. Customer segments span health-conscious consumers (DTC via digital platforms), healthcare practitioners (B2B Rx channel), and regional distribution partners; products reach consumers via HCP prescription, retail pharmacy, company websites, and Maxx Care's third-party distribution.

Name

Mega Lifesciences

Legal name

MEGA Lifesciences Public Company Limited

Website

https://megawecare.com

Company type

Public

Founded year

1982

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Mega Lifesciences is a Thailand-based public pharmaceutical and nutraceutical company that manufactures, markets and distributes 500+ OTC supplements and prescription medicines across 30+ countries under the Mega We care brand.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Nutraceutical Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Pharmaceutical manufacturing
• Nutraceutical supplements
• Prescription medicines
• Wellness products
• Pharmaceutical distribution

Headquarters

HQ city

Bang Na

HQ country

Thailand

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products: Prescription medicines across multiple therapy areas including anti-infective, cardiovascular, dermatology, diabetes, gastrointestinal, gynaecology, and more
2. Nutraceuticals and Supplements: Over-the-counter wellness and nutritional supplements including vitamins, probiotics, herbal meds, sports nutrition, and medical nutrition
3. Distribution Business: Market access solutions through Maxx Care brand in Myanmar, Vietnam and Cambodia
4. Wellness Services: Wellness programs and health training services including the Wellness We Care Center programs

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mega Lifesciences manufactures, markets, sells, and distributes pharmaceutical (prescription) and nutraceutical (OTC) products across 30+ countries. The company develops science-backed supplements, vitamins, probiotics, and specialized nutrition products, alongside a prescription medicines portfolio covering more than 15 therapy areas. It also operates digital wellness platforms and a regional distribution service (Maxx Care) for market access.

Product overview

Mega Lifesciences (Mega We care) is a pharmaceutical and wellness company operating across 30+ countries with a portfolio of 500+ quality products. The company's product portfolio is organized into three main categories: (1) Wellness & Nutrition - consumer health supplements including vitamins (NAT B, NAT C, VITAMIN A 25000 IU), minerals (Calcivita Forte, Maxcal, Cal D Chewz), probiotics (NORMAGUT, NORMAGUT INSTA), herbal medicines, bone & joint care (Flexsa 1500, Gogaz), liver care (Livolin Forte, Lecithin), and specialized products for men (CHARZ ORANGE, ULTRAPRO ISOLATE, REKOVER), women (FERROVIT, GINSOMIN EVE, EVENING PRIMROSE OIL), and children (FERROTONE LIQUIZ, CALCOD, GOGAZ BABY, KIDDZ MAXXOMEGA 3); (2) Prescription Medicines across 15 therapy areas including Anti-Allergic, Anti Infective, Cardiology, Dermatology, Diabetes, Gastrointestinal, Gynaecology, Nephrology, Neurology, Oncology, Ophthalmology, Orthopaedic, Pain, Respiratory, Rheumatology, and Urology; and (3) Digital Health Platforms including Wellness We care Center (Thailand's first health training facility), Good Health By Yourself (digital health education), Women We care (women's wellness platform), and Health Apps (joinwecare for diabetes, mother & child, and wellness management). The company emphasizes a nature-inspired, science-backed approach to product development.

Differentiator

Problem solved

Functional benefit

Brands

• BiO-LiFE: Health supplements brand in Malaysia with over three decades of commitment to quality and consumer wellbeing
• Maxx Care
• Natural We Care
• Wellness We Care
• Good Health By Yourself
• Women We care
• Health Home We Care
• MEGA BiO-LiFE
• Eugica

Products and services

• Calcivita Forte
• Flexsa 1500
• Normagut
• Normagut Insta
• Gogaz
• Livolin Forte
• Enat
• Ferrovit
• Ginsomin Eve
• Nat C
• Nat B / Nat B Fizzy
• Maxizorb E
• Gofen
• Eugica
• Ultrapro Isolate
• Rekover
• Glucomeal Vanilla
• Cal D Chewz / Calcod
• Kiddz Maxxomega 3
• Prescription Medicines Portfolio
• Maxx Care Distribution Services
• Wellness We Care Center
• Good Health By Yourself Digital Platform
• Women We Care Platform
• Joinwecare Health Apps

Quantifiable outcome

• 4.2% branded business growth in Q4 2025
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Healthcare Institutions and Medical CenterscoreStrategic or Co-development PartnerPartnerships with medical institutions for continuing medical education, conference support, and healthcare practitioner training programs including Borneo Medical Centre Malaysia for osteoporosis management events

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Blackmores: Australian-headquartered natural health and supplements company with a broad vitamins, minerals, and herbal range sold across Asia-Pacific. Directly comparable to Mega Lifesciences' BiO-LiFE and wellness/nutraceutical portfolio across SEA.
• Dabur India: India-based Ayurvedic and natural health products company with a sizable international presence across South Asia, Middle East, and Africa. Comparable to Mega Lifesciences in branded herbal supplements, OTC, and emerging-market distribution.
• Kalbe Farma: Indonesia's largest pharmaceutical company, distributing prescription medicines, OTC products, and nutritional supplements across Southeast Asia. Closely comparable to Mega Lifesciences' prescription + nutraceutical mix and SEA distribution model.

Broad incumbents

• Bayer Consumer Health: Global OTC and consumer health division of Bayer, covering vitamins, supplements, and self-care products across emerging markets including SEA. Competes with Mega Lifesciences in OTC categories such as vitamins and pain care.
• Sun Pharmaceutical Industries: India's largest specialty generics manufacturer with presence across chronic therapy areas (cardiology, dermatology, oncology). Overlaps with Mega Lifesciences' prescription medicine portfolio, though at much larger scale and broader global reach.
• Reckitt Benckiser (Health): Global consumer health company with OTC, nutrition, and wellness brands distributed widely in Southeast Asia. Comparable to Mega Lifesciences in OTC supplements and consumer health, though as a much larger multinational incumbent.
• Abbott Nutrition: Global nutrition business with strong medical and sports nutrition portfolio across Asia. Overlaps with Mega Lifesciences' medical nutrition, diabetic care, and sports nutrition segments.

Regional players

• Sime Darby Healthcare / Duopharma Biotech: Malaysia-based pharmaceutical manufacturer serving prescription, OTC, and consumer health categories across Southeast Asia. Directly comparable geography and channel mix to MEGA BiO-LiFE Malaysia and the broader Mega Lifesciences SEA business.
• T.C. Pharmaceutical Industries (T.C.P.): Thai pharmaceutical and consumer health company with similar regional SEA presence. Comparable to Mega Lifesciences in Thailand-domestic prescription and OTC supplements, and a likely regional competitor.

Emerging players

• Pharmacare (Aspen Pharmacare): South African-headquartered pharmaceutical manufacturer and distributor with emerging-markets focus across Africa and Asia. Comparable to Mega Lifesciences in distribution-led expansion into frontier healthcare markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Megawecarecorp
• Facebookfacebook.com/MegaWeCareGlobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mega Lifesciences